Oral Candida spp carriers: Its prevalence in patients with type 2 diabetes Mellitus;Portadores de Candida spp na cavidade oral: A sua prevalência em pacientes com diabetes Mellitus tipo 2

Anais Brasileiros de Dermatologia

Volumn 88, Issue 2, 2013, Pages 222-225

  Martinez, Ramon Felipe Fernandez ^a   Hernández Pérez, Francisco ^a   Miguel, Guadalupe Fabián San ^b   Jaimes Aveldañez, Alejandra ^a   Arenas, Roberto ^a  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Candida; Diabetes mellitus; Mexico; Mouth; Type 2

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CANDIDA ALBICANS; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; FEMALE; GRAM STAINED EXFOLIATIVE CYTOLOGY; HUMAN; HYPOSALIVATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OPEN STUDY; ORAL MUCOSAL DISEASE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SALIVATION; SIALOMETRY TEST; SMOKING; THRUSH; TOOTH PROSTHESIS;

EID: 84878184950     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962013000200006     Document Type: Article

References (20)

1. Ship JA. Diabetes and oral health: an overview. J AmDent Assoc. 2003; 134 supl: 4-10.
2. Nevazesh M, Garay J, Vernon J. Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 1995;80: 284-8.
3. Shlossman, Knowler, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc.1990;121:532-6.
4. López-Jornet P, Saura-Inglés A, Martínez-Mondéjar B, Bermejo-Fenoll A. Valoración de latasa de flujo salival en pacientes con diabetes tipo 1 y tipo 2. Archivos de Odontoestomatol. 1996;12:690-7.
5. Guggenheimer J, Moore PA, Rossie K, Myers D, Mongelluzzo MB, Block HM, et al. Insulindependent Diabetes Mellitus and oral tissuepathologies II. Prevalence and characteristics of Candida and candidal lesions. Oral Surg Oral Med Oral Radiol Endod.2000;89:570-6.
6. Molina SD, Monroy E, Arenas R, Fernández RF, Rubalcaba PJ, Fabián SMG. Frecuencia de candidiasis oral en pacientes diabéticos tipo 2ambulatoriosenel Hospital General Dr. Manuel Gea González. Estudio Clínico Micológico. Dermatología Rev Mex.2002;46:3-9.
7. De la Rosa E, Aranda S, Cruz S, Mondragón A. Frecuencia de manifestacionesbucalesen pacientes diabéticos tipo 2 de una unidad de medicina familiar del IMSS. Rev Cienc Clín.2006;2:81-8.
8. Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, Baka D, et al. Candidalovergrowth in diabeticpatients: potentialpredisposingfactors. Mycoses 2005;48:192-6.
9. Lynch DP. Oral candidiasis.History, classification, and clinical presentation. Oral Med Oral Pathol Oral. 1994;78:189-93.
10. Goldschmidt MC, Fung DY, Grant R, White J, Brown T. New aniline blue dye medium for rapid identification and isolation of Candida albicans. J Clin Microbiol 1991;29:1095-9.
11. Hoppe JE, Frey P. Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans. Eur J Clin Microbiol Infect Dis 1999;18:188-91.
12. Bauters TG, Moerman M, Vermeersch H, Nelis HJ. Colonization of voice prostheses by albicans and non-albicans Candida species. Laryngoscope. 2002;112:708-12.
13. Waller J, Koenig H, Debruyne M, Contant G. Evaluation d'un nouveau milieu isolement des levures et de diagnostiquerapide de Candida albicans. Rev Fr Lab. 1993;252:89-92.
14. Freydier AM, Buchaille L, Gille Y. Comparison of three commercial media for direct identification and discrimination of Candida species in clinical specimens. Eur J Clin Microbiol Infect Dis. 1997;16:464-7.
15. Cooke VM, Miles RJ, Price RG, Midgley G, Khamri W, Richardson AC. New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol.2002;68:3622-7.
16. Bernal S, Martin Mazuelos E, Garcia M, Aller AI, Martinez MA, Gutierrez MJ. Evaluation of CHROMagar candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis. 1996;24:201-4.
17. Odds FC, Bernaerts R. CHROMagar candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994;32:1923-9.
18. Scarparo C, Piccoli P, Ricordi P, Scagnelli M. Comparative evaluation of two commercial chromogenic media for detection and presumptive identification of urinary tract pathogens. Eur J Clin Microbiol Infect Dis. 2002;21:283-9.
19. Momani OM. Cost-effectiveness and efficacy of CHROMagar candida medium in clinical specimens. East Mediterr Health J. 2000;6:968-78.
20. Ramírez AV, Mosqueda TA, Hernández LLH. Estudio epidemiológico de las lesiones de la mucosa oral. México. Cuadernos de C.B.S. No.11. U.A.M.X. 1986. 75 p.